Espinoza-Gutarra MR - Search Results

1

Immune-Based Therapeutic Interventions for Acute Myeloid Leukemia.

Perna F, Espinoza-Gutarra MR, Bombaci G, Farag SS, Schwartz JE. Perna F, et al. Among authors: espinoza gutarra mr. Cancer Treat Res. 2022;183:225-254. doi: 10.1007/978-3-030-96376-7_8. Cancer Treat Res. 2022. PMID: 35551662

2

CD123-targeted therapy in acute myeloid leukemia.

Espinoza-Gutarra MR, Green SD, Zeidner JF, Konig H. Espinoza-Gutarra MR, et al. Expert Rev Hematol. 2021 Jun;14(6):561-576. doi: 10.1080/17474086.2021.1935855. Epub 2021 Jun 14. Expert Rev Hematol. 2021. PMID: 34043467

3

A case report of the metagenomics next-generation sequencing for early detection of central nervous system mucormycosis with successful rescue in patient with recurrent chronic lymphocytic leukemia.

Zhang J, Luo J, Weng X, Zhu Y, Goyal G, Perna F, Espinoza-Gutarra M, Jiang L, Chen L, Mi JQ. Zhang J, et al. Ann Transl Med. 2022 Jun;10(12):722. doi: 10.21037/atm-22-2533. Ann Transl Med. 2022. PMID: 35845522 Free PMC article.

4

Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies.

Schorr C, Forindez J, Espinoza-Gutarra M, Mehta R, Grover N, Perna F. Schorr C, et al. Int J Mol Sci. 2023 May 6;24(9):8349. doi: 10.3390/ijms24098349. Int J Mol Sci. 2023. PMID: 37176053 Free PMC article.

5

Cancer-related knowledge, beliefs, and behaviors among Hispanic/Latino residents of Indiana.

Espinoza-Gutarra MR, Rawl SM, Maupome G, O'Leary HA, Valenzuela RE, Malloy C, Golzarri-Arroyo L, Parker E, Haunert L, Haggstrom DA. Espinoza-Gutarra MR, et al. Cancer Med. 2023 Mar;12(6):7470-7484. doi: 10.1002/cam4.5466. Epub 2023 Jan 22. Cancer Med. 2023. PMID: 36683200 Free PMC article.

6

West Nile Encephalitis, an Unusual Infection in a Chronic Lymphocytic Leukemia Patient.

Espinoza-Gutarra MR, Cervantez SL, Nooruddin Z. Espinoza-Gutarra MR, et al. Case Rep Hematol. 2018 Oct 14;2018:3270348. doi: 10.1155/2018/3270348. eCollection 2018. Case Rep Hematol. 2018. PMID: 30405921 Free PMC article.

7

The Problem of Hispanic/Latinx Under-Representation in Cancer Clinical Trials.

Espinoza-Gutarra MR, Duma N, Aristizabal P, Segarra-Vazquez B, Borno H, Halbert CH, Simon MA, Velazquez AI. Espinoza-Gutarra MR, et al. JCO Oncol Pract. 2022 May;18(5):380-384. doi: 10.1200/OP.22.00214. JCO Oncol Pract. 2022. PMID: 35544652 No abstract available.

8

Outcomes in chronic lymphocytic leukemia patients on novel agents in the US Veterans Health Administration System.

Frei CR, Le H, McHugh D, Ryan K, Jones X, Galley S, Franklin K, Baus CJ, Tavera J, Janania-Martinez M, Gregorio D, Ananth S, Uribe R, Surapaneni P, Espinoza-Gutarra M, Song MM, Teng C, Obodozie-Ofoegbu OO, Nooruddin Z. Frei CR, et al. Leuk Lymphoma. 2021 Jul;62(7):1664-1673. doi: 10.1080/10428194.2021.1876863. Epub 2021 Feb 11. Leuk Lymphoma. 2021. PMID: 33569992

9

Factors Associated with Cancer Prevention/Risk Reduction Behaviors among Latinos.

Rawl SM, Maupome G, Golzarri-Arroyo L, Parker E, O'Leary HA, Espinoza-Gutarra MR, Valenzuela RE, Malloy C, Haunert L, Haggstrom DA. Rawl SM, et al. Among authors: espinoza gutarra mr. J Racial Ethn Health Disparities. 2023 Dec 20. doi: 10.1007/s40615-023-01895-w. Online ahead of print. J Racial Ethn Health Disparities. 2023. PMID: 38117442

10

Clinical trial design change implementation for inclusive studies.

Espinoza-Gutarra MR, Aiello J, Orlowski RZ, Ailawadhi S. Espinoza-Gutarra MR, et al. Lancet Haematol. 2023 Dec;10(12):e953-e954. doi: 10.1016/S2352-3026(23)00336-8. Lancet Haematol. 2023. PMID: 38030317 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page